Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670506 | SCV000795365 | pathogenic | Cockayne syndrome type 1 | 2017-11-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000809115 | SCV000949255 | pathogenic | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu132Asnfs*6) in the ERCC8 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC8 are known to be pathogenic (PMID: 29572252). This variant is present in population databases (rs774542633, gnomAD 0.006%). This premature translational stop signal has been observed in individuals with Cockayne syndrome (PMID: 26173784, 29057985). ClinVar contains an entry for this variant (Variation ID: 554811). For these reasons, this variant has been classified as Pathogenic. |